跳至主要内容
临床试验/ISRCTN02260579
ISRCTN02260579已完成不适用

Percutaneus subclavian versus internal jugular versus cephalic surgical venous cut-down for central venous access of totally implantable ports for long-term chemotherapy: a prospective randomised trial

European Institute of Oncology (Italy)0 个研究点目标入组 750 人开始时间: 2009年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
750

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients (aged 18 - 75 years, either sex) bearing solid tumours who are candidate to chemotherapy treatment for at least 4 months
  • 2. Informed signed consent
  • 3. Performance status 0 - 2 (according to Eastern Cooperative Oncology Group [ECOG] score)
  • 4. Platelets greater than 50,000/mm^3
  • 5. Prothrombin time (quick) greater than 60%
  • 6. White blood cells greater than 2500/mm^3
  • 7. Life expectancy greater than 6 months

排除标准

  • 1. Severe hepatic failure (ascites, portal hypertension, jaundice or encephalopathy)
  • 2. Renal failure (haemodyalisis and creatinine greater than 2.5 mg/dL)
  • 3. Active infections
  • 4. Coagulopathy
  • 5. Inability to give an informed consent

研究者

发起方
European Institute of Oncology (Italy)

相似试验

Totally Implantable Access Ports | 临床试验